APA (7th ed.) Citation

E, V., D, M., JD, S., K, W., CL, N., CM, L., . . . NJ, L. (2022). Whole-genome sequencing as an investigational device for return of hereditary disease risk and pharmacogenomic results as part of the All of Us Research Program. Genome medicine, 14(1), 34. https://doi.org/10.1186/s13073-022-01031-z

Chicago Style (17th ed.) Citation

E, Venner, et al. "Whole-genome Sequencing as an Investigational Device for Return of Hereditary Disease Risk and Pharmacogenomic Results as Part of the All of Us Research Program." Genome Medicine 14, no. 1 (2022): 34. https://doi.org/10.1186/s13073-022-01031-z.

MLA (9th ed.) Citation

E, Venner, et al. "Whole-genome Sequencing as an Investigational Device for Return of Hereditary Disease Risk and Pharmacogenomic Results as Part of the All of Us Research Program." Genome Medicine, vol. 14, no. 1, 2022, p. 34, https://doi.org/10.1186/s13073-022-01031-z.